Science Translational Medicine
03 July 2019 Vol 11, Issue 499
Design of vaccine efficacy trials during public health emergencies
By Natalie E. Dean, Pierre-Stéphane Gsell, Ron Brookmeyer, Victor De Gruttola, Christl A. Donnelly, M. Elizabeth Halloran, Momodou Jasseh, Martha Nason, Ximena Riveros, Conall H. Watson, Ana Maria Henao-Restrepo, Ira M. Longini
Science Translational Medicine03 Jul 2019 Restricted Access
Public health emergencies, such as an Ebola disease outbreak, provide a complex and challenging environment for the evaluation of candidate vaccines. Here, we outline the need for flexible and responsive vaccine trial designs to be used in public health emergencies, and we summarize recommendations for their use in this setting.